Osteoprotegerin is Associated With Major Bleeding but Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes - Insights From the PLATelet Inhibition and Patient Outcomes (PLATO) Trial

被引：0
|
作者：
Ueland, Thor
Akerblom, Axel
Ghukasyan, Tatevik
Michelsen, Annika E.
Aukrust, Pal
Becker, Richard C.
Bertilsson, Maria
Himmelmann, Anders
James, Stefan K.
Siegbahn, Agneta
Storey, Robert F.
Kontny, Frederic
Wallentin, Lars
机构：
来源：
CIRCULATION | 2016年 / 134卷
关键词：
Biomarkers; Acute coronary syndromes; Hemorrhage; Mortality; Inflammation and inflammatory markers;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
12851
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial
    Ueland, Thor
    Akerblom, Axel
    Ghukasyan, Tatevik
    Michelsen, Annika E.
    Aukrust, Pal
    Becker, Richard C.
    Bertilsson, Maria
    Himmelmann, Anders
    James, Stefan K.
    Siegbahn, Agneta
    Storey, Robert F.
    Kontny, Frederic
    Wallentin, Lars
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (02):
  • [2] Osteoprotegerin is Associated With Major Bleeding but Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes - Insights From the PLATelet Inhibition and Patient Outcomes (PLATO) Trial
    Ueland, Thor
    Akerblom, Axel
    Ghukasyan, Tatevik
    Michelsen, Annika E.
    Aukrust, Pal
    Becker, Richard C.
    Bertilsson, Maria
    Himmelmann, Anders
    James, Stefan K.
    Siegbahn, Agneta
    Storey, Robert F.
    Kontny, Frederic
    Wallentin, Lars
    [J]. CIRCULATION, 2016, 134
  • [3] SERUM URIC ACID IS ASSOCIATED WITH CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROMES: RESULTS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL
    Akerblom, Axel
    James, Stefan
    Bertilsson, Maria
    Himmelmann, Anders
    Huhn, Monika
    Pieper, Karen
    Husted, Steen
    Storey, Robert
    Becker, Richard
    Wallentin, Lars
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 556 - 556
  • [4] Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial
    Gregersen, Ida
    Michelsen, Annika E.
    Ngoc Nguyen Lunde
    Akerblom, Axel
    Lakic, Tatevik G.
    Skjelland, Mona
    Skagen, Karolina Ryeng
    Becker, Richard C.
    Lindback, Johan
    Himmelmann, Anders
    Solberg, Rigmor
    Johansen, Harald T.
    James, Stefan K.
    Siegbahn, Agneta
    Storey, Robert F.
    Kontny, Frederic
    Aukrust, Pal
    Ueland, Thor
    Wallentin, Lars
    Halvorsen, Bente
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (17):
  • [5] Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
    Akerblom, Axel
    Wojdyla, Daniel M.
    Wallentin, Lars
    James, Stefan K.
    Brito, Flavio de Souza
    Steg, Philippe Gabriel
    Cannon, Christopher P.
    Katus, Hugo A.
    Himmelmann, Anders
    Storey, Robert F.
    Becker, Richard C.
    Lopes, Renato D.
    [J]. AMERICAN HEART JOURNAL, 2019, 213 : 57 - 65
  • [6] ST-Elevation Acute Coronary Syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) Trial Insights From the ECG Substudy
    Armstrong, Paul W.
    Siha, Hany
    Fu, Yuling
    Westerhout, Cynthia M.
    Steg, Ph. Gabriel
    James, Stefan K.
    Storey, Robert F.
    Horrow, Jay
    Katus, Hugo
    Clemmensen, Peter
    Harrington, Robert A.
    Wallentin, Lars
    [J]. CIRCULATION, 2012, 125 (03) : 514 - U131
  • [7] Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
    Axel Åkerblom
    Daniel Wojdyla
    Philippe Gabriel Steg
    Lars Wallentin
    Stefan K. James
    Andrzej Budaj
    Hugo A. Katus
    Anders Himmelmann
    Kurt Huber
    Agneta Siegbahn
    Robert F. Storey
    Richard C. Becker
    [J]. Journal of Thrombosis and Thrombolysis, 2019, 48 : 563 - 569
  • [8] Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
    Akerblom, Axel
    Wojdyla, Daniel
    Steg, Philippe Gabriel
    Wallentin, Lars
    James, Stefan K.
    Budaj, Andrzej
    Katus, Hugo A.
    Himmelmann, Anders
    Huber, Kurt
    Siegbahn, Agneta
    Storey, Robert F.
    Becker, Richard C.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (04) : 563 - 569
  • [9] PRIOR SMOKING STATUS, CLINICAL OUTCOMES, AND THE COMPARISON OF TICAGRELOR WITH CLOPIDOGREL IN ACUTE CORONARY SYNDROMES - INSIGHTS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL
    Cornel, Jan Hein
    Becker, Richard
    Goodman, Shaun
    Husted, Steen
    Katus, Hugo
    Santoso, Anwar
    Steg, Philippe
    Storey, Robert
    Vintila, Marius
    Sun, Jie
    Horrow, Jay
    Wallentin, Lars
    Harrington, Robert
    James, Stefan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E495 - E495
  • [10] Correlation of Inhibition of Platelet Aggregation With Cardiovascular and Bleeding Outcomes in Acute Coronary Syndromes
    Wada, Russ
    Rohatagi, Shashank
    Small, David
    Winters, Kenneth J.
    Salazar, Daniel E.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (08): : 904 - 913
12345